Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 37
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03316820 | Bioavailability Study of K0706 in Healthy Subjects | ||
| NCT03450629 | Evaluation of Safety and Efficacy of PDP-716 | ||
| NCT02629692 | Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies | ||
| NCT01614691 | Safety and Efficacy of SPARC1203 in Allergic Rhinitis | ||
| NCT02041221 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316 | ||
| NCT01132521 | Ulinastatin in Severe Acute Pancreatitis | ||
| NCT01304303 | Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination | ||
| NCT03055143 | Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer | ||
| NCT03445338 | To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers | ||
| NCT00862355 | Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer | ||
| NCT02618395 | Bioavailability Study of SPARC001 in Healthy Adult Volunteers | ||
| NCT01940146 | Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis | ||
| NCT01305512 | Pharmacokinetic, Safety and Tolerability Study of SPARC1028 | ||
| NCT03426267 | Evaluation of Efficacy and Safety of SDN-037 | ||
| NCT03996460 | K0706 for Patients Diagnosed With Dementia With Lewy Bodies | ||
| NCT02597465 | A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 | ||
| NCT02027025 | Study of SPARC1103 in Subjects With Spasticity | ||
| NCT00863174 | A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma | ||
| NCT02346058 | Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins | ||
| NCT00945958 | Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension | ||
| NCT02991222 | Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers | ||
| NCT03567941 | To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen | ||
| NCT03655236 | PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 | ||
| NCT01457352 | Efficacy and Safety of SPARC0921 in Subjects With Spasticity | ||
| NCT04332549 | To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT03109249 | Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT02887534 | Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain | ||
| NCT02991261 | Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers | ||
| NCT02136927 | Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer | ||
| NCT02970019 | Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease | ||
| NCT07042100 | A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. | ||
| NCT00947661 | Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension | ||
| NCT01797185 | Safety Study of SPARC1104 | ||
| NCT01320553 | Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis | ||
| NCT04942054 | A Study in Patients With Advanced Breast Cancer | ||
| NCT04242953 | Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects | ||
| NCT06662877 | Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment |
